secwatch.observer — SEC 8-K summary
======================================

Issuer:     AXT INC (AXTI)
CIK:        0001051627
Form:       8-K
Filed at:   2025-07-23T23:59:59+00:00
Accession:  0001437749-25-023321
Event type: regulatory
Sentiment:  negative
Materiality: 0.45
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AXT non-compliant with Nasdaq audit committee rules after director death; cure period through mid-2026
--------------------------------------------------------------------------------

- Passing of director Christine Russell left Audit Committee with only two independent directors, violating Nasdaq Rule 5605(c)(2)(A).
- Nasdaq granted cure period: compliance required by earlier of next annual meeting or July 11, 2026.
- If 2025 annual meeting held before Jan 7, 2026, compliance deadline is Jan 7, 2026 instead.
- Company intends to regain compliance by appointing a new independent director meeting Nasdaq requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051627/000143774925023321/0001437749-25-023321-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051627/000143774925023321/axti20250722_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-023321

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer